Personal information

Emails & domains

Verified email domains

Websites & social links

CCCB Lab Web Page
CCCB lab Twitter-X
Google Scholar

Other IDs

Scopus Author ID: 7801426354

Keywords

Oncology, Cancer, Cell Cycle, Mitosis, Kinases, Cell Biology

Countries

Spain

Activities

Collapse all

Employment (4)

Instituto de Investigaciones Biomédicas Sols-Morreale: Madrid, ES

2018-10-01 to present | Group Leader (Cancer Biology)
Employment
Source: Self-asserted source
Guillermo de Cárcer

Centro Nacional de Investigaciones Oncológicas: Madrid, Madrid, ES

2007-01-01 to 2018-09-30 | Tenured Scientist (Molecular Oncology Program)
Employment
Source: Self-asserted source
Guillermo de Cárcer

Centro Nacional de Investigaciones Oncológicas: Madrid, Madrid, ES

2002-01-01 to 2006-12-31 | Tenure Track Researcher (Molecular Oncology)
Employment
Source: Self-asserted source
Guillermo de Cárcer

EMBL Heidelberg Genome Biology: Heidelberg, Baden-Württemberg, DE

1999-01-01 to 2001-12-31 | Postdoctoral fellow (Cell Biology)
Employment
Source: Self-asserted source
Guillermo de Cárcer

Education and qualifications (2)

Centro de Investigaciones Biológicas: Madrid, Madrid, ES

1995-03-01 to 1997-12-09 | PhD (Cell Biology Department)
Education
Source: Self-asserted source
Guillermo de Cárcer

Universidad Autonoma de Madrid Facultad de Ciencias: Madrid, Madrid, ES

1988-10-01 to 1994-06-01 | Master Science (Biochemistry and Molecular Biology)
Education
Source: Self-asserted source
Guillermo de Cárcer

Funding (3)

STUDY OF NEW TUMORAL AND PHYSIOLOGICAL BIOMARKERS ASSOCIATED TO THE CANCER TARGET PLK1

2022-09 to 2025-08 | Grant
Agencia Estatal de Investigación (Madrid, Madrid, ES)
GRANT_NUMBER:

PID2021-125705OB-I00
Source: Self-asserted source
Guillermo de Cárcer

IDENTIFICATION OF THE ONCOGENIC MECHANISMS ASSOCIATED WITH THE MITOTIC KINASE PLK1

2019-09 to 2021-09 | Grant
Ministerio de Ciencia e Innovación (Madrid, Madrid, ES)
GRANT_NUMBER:

RTI2018-095496-B-I00
Source: Self-asserted source
Guillermo de Cárcer

IDENTIFICATION OF NEW BIOMARKERS FOR BREAST CANCER: MECHANISMS OF SENSITIVITY AND RESISTANCE TO CELL CYCLE RELATED DRUGS.

2017-12 to 2021-12 | Grant
Fundación Científica Asociación Española Contra el Cáncer (Madrid, ES)
GRANT_NUMBER: LABAE16017DECA
Source: Self-asserted source
Guillermo de Cárcer

Peer review (8 reviews for 5 publications/grants)

Review activity for Advanced science. (2)
Review activity for Biochimica et biophysica acta. (1)
Review activity for Cancers. (1)
Review activity for Cell death and disease. (2)
Review activity for Nature communications (2)
How many people are using ORCID?